¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Egyptian hematuria"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® hematuria ÇÑ±Û Ç÷´¢
¼³¸í   
  ¿ÀÁÜ¿¡ ÀûÇ÷±¸°¡ ¼¯ÀΠ°Í. ÀûÇ÷±¸°¡ ÆÄ±«µÇ¾î Ç÷»ö¼Ò°¡ ¼¯¿© Àִ °ÍÀº Ç÷»ö¼Ò´¢¶ó°í ÇÏ¿© ±¸º°ÇÑ´Ù. Ç÷´¢´Â »¡°²°í Å¹ÇÏ¿© ½±°Ô ¾Ë ¼ö Àִ °Íµµ ÀÖÁö¸¸(À°¾ÈÀû Ç÷´¢), °¡º­¿î °ÍÀº ¿¯°Ô ¼¯¿© À־ ºÓÀº±â°¡ ¾øÀ¸¹Ç·Î, Çö¹Ì°æÀ¸·Î Ç÷±¸¸¦ Á¶»çÇØ º¸¾Æ¾ß ÇÑ´Ù(Çö¹Ì°æÀû Ç÷´¢). ¶§·Î´Â ¾Ï°¥»ö ¶Ç´Â °ËÀº±â¸¦ ¶ì´Â °Íµµ ÀÖ´Ù. ¿ä»ê¿°´¢-¾àÁ¦(»êÅä´ÑÀ̳ª ´ëȲ µî)-À½½Ä(¿Àµð³ª Âø»ö½Äǰ)À¸·Î Ç÷´¢¿Í ºñ½ÁÇÑ ºÓÀº±â¸¦ ¶ì´Â ÀÏÀÌ ÀÖÀ¸¹Ç·Î ÁÖÀÇÇØ¾ß ÇÑ´Ù. Ç÷´¢´Â ¿ä·Î(ÄáÆÏ-¿ä°ü-¹æ±¤-¿äµµ)ÀÇ ¾î¶² ºÎÀ§¿¡¼­µµ ³ªÅ¸³¯ ¼ö Àִµ¥, ¿ÀÁÜÀ» Ã¤ÃëÇØ º¸¸é ¾îµð¼­ ÃâÇ÷Çϰí Àִ°¡¸¦ ÆÇ´ÜÇÒ ¼ö ÀÖ´Ù. Ã³À½ºÎÅÍ ³¡±îÁö Ç÷´¢(ÀüÇ÷´¢)À̸é ÄáÆÏ-¿ä°ü-¹æ±¤ÀÇ ÃâÇ÷, ¿ÀÁÜÀÇ ³¡¿¡ Ç÷´¢°¡ µÇ´Â °ÍÀº(Á¾¸»Ç÷´¢) ¹æ±¤¸ñ-Èĺο䵵·ÎºÎÅÍÀÇ ÃâÇ÷, ¿ÀÁÜÀÇ ½ÃÀÛ¿¡ Ç÷´¢°¡ ³ª¿À´Â °ÍÀº(ÃʱâÇ÷´¢) ¿äµµ·ÎºÎÅÍÀÇ ÃâÇ÷ÀÌ´Ù. Ç÷´¢°¡ »ý±â´Â º´Àº ÄáÆÏ¿¡¼­´Â ÄáÆÏ¿°-ÄáÆÏ°áÇÙ-ÄáÆÏÁ¾¾ç-ÄáÆÏ°á¼®-¹°ÄáÆÏ-¿Ü»ó-Ư¹ß¼º ÃâÇ÷ µîÀ̸ç, ¿ä°ü¿¡¼­´Â °á¼®-Á¾¾ç µîÀ̰í, ¹æ±¤¿¡¼­´Â ¹æ±¤¿°-Á¾¾ç-°á¼® µîÀ̰í, ¿äµµ¿¡¼­´Â ¿äµµ¿° µîÀÌ ¿øÀÎÀÌ µÈ´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • asymptomatic hematuria
    ¹«Áõ»óÇ÷´¢
  • exercise hematuria
    ¿îµ¿Ç÷´¢
  • essential hematuria
    º»ÅÂÇ÷´¢, ¿øÀκҸíÇ÷´¢
  • false hematuria
    °ÅÁþÇ÷´¢, °¡¼ºÇ÷´¢
  • gross hematuria
    À°¾ÈÀûÇ÷´¢, ¸Ç´«Ç÷´¢
  • hematuria
    Ç÷´¢
  • initial hematuria
    ÃʱâÇ÷´¢
  • microscopic hematuria
    Çö¹Ì°æÀûÇ÷´¢, ¹Ì¼¼Ç÷´¢
  • occult hematuria
    ÀáÀçÇ÷´¢, ¿äÀáÇ÷
  • painless hematuria
    ¹«ÅëÇ÷´¢
  • renal hematuria
    ÄáÆÏÇ÷´¢, ½ÅÀ强Ç÷´¢
  • schistosomal hematuria
    ÁÖÇ÷ÈíÃæÇ÷´¢
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hematuria
    Ç÷´¢
  • microscopic hematuria
    ¹Ì¼¼Ç÷´¢
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • asymptomatic hematuria
    ¹«Áõ»óÇ÷´¢
  • essential hematuria
    ¿øÀκҸíÇ÷´¢, ¼ø¼öÇ÷´¢
  • exercise hematuria
    ¿îµ¿Ç÷´¢
  • false hematuria
    °ÅÁþÇ÷´¢
  • gross hematuria
    ¸Ç´«Ç÷´¢
  • hematuria
    Ç÷´¢
  • initial hematuria
    ÃʱâÇ÷´¢
  • occult hematuria
    ÀẹÇ÷´¢
  • painless gross hematuria
    ¹«Åë¸Ç´«Ç÷´¢
  • renal hematuria
    ÄáÆÏÇ÷´¢
  • schistosomal hematuria
    ÁÖÇ÷ÈíÃæÇ÷´¢
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gross hematuria
    À°¾ÈÀû Ç÷´¢.
  • hematocyturia =hematuria
    Ç÷´¢(Áõ) (úìèññø).
  • hematuresis =hematuria
    Ç÷´¢(úìèñ).
  • hematuria
    Ç÷´¢(úìèñ)(Áõ).
  • hematuria
    Ç÷´¢(Áõ)(úìÒã)
  • hematuria
    Ç÷´¢
  • initial hematuria
    ¹è´¢ÃʱâÇ÷´¢.
  • initial hematuria
    ÃʱâÇ÷´¢Áõ.[ºñ´¢]¹è´¢ÃʱâÇ÷´¢.
  • renal hematuria
    ½Å¼º Ç÷´¢Áõ(ãìàõúìèññø).
  • renal hematuria
    ½Å¼º Ç÷´¢Áõ(¡­úìèññø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • asymptomatic hematuria
    ¹«Áõ»óÇ÷´¢.
  • cystoscopy for hematuria
    ¹æ±¤°æ
  • endemic hematuria
    Áö¹æº´¼º Ç÷´¢Áõ(ÊÙÌ´ËíÌ¡).
  • episode of hematuria
    Ç÷´¢¹ßÀÛ.
  • essential hematuria
    º»Å¼º Ç÷´¢.
  • exercise-induced hematuria
    ¿îµ¿À¯¹ßÇ÷´¢
  • false hematuria
    °¡¼ºÇ÷´¢(Áõ)(¡­úìèññø).
  • gross hematuria
    À°¾ÈÀû Ç÷´¢.
  • hematocyturia =hematuria
    Ç÷´¢(Áõ) (úìèññø).
  • hematuresis =hematuria
    Ç÷´¢(úìèñ).
  • hematuria
    Ç÷´¢
  • hematuria
    Ç÷´¢(úìèñ)(Áõ).
  • hematuria
    Ç÷´¢(Áõ)(úìÒã)
  • initial hematuria
    ÃʱâÇ÷´¢Áõ.[ºñ´¢]¹è´¢ÃʱâÇ÷´¢.
  • initial hematuria
    ¹è´¢ÃʱâÇ÷´¢.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • schistosomal hematuria
    ÁÖÇ÷ÈíÃæÇ÷´¢
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hematuria
    Ç÷´¢Áõ
  • microscopic hematuria
    Çö¹Ì°æÀûÇ÷´¢
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
BFH benign familial hematuria
BRH benign recurrent hematuria; Bureau of Radiological Health
NFH heavy polypeptide of neurofilament protein; nonfamilial hematuria
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • asymptomatic hematuria
    ¹«Áõ»ó Ç÷´¢
  • micoscopic hematuria
    Çö¹Ì°æÀû Ç÷´¢
  • total hematuria
    Àü Ç÷´¢Áõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
hematuria <clinical sign, urology> The finding of blood in the urine.
Origin: Gr. Ouron = urine
(18 Nov 1997)
egyptian Pertaining to Egypt, in Africa. Egyptian bean.
<botany> A medium-sized tree (Acacia vera). It is one of the chief sources of the best gum arabic.
Origin: L. Aegyptius, Gr, fr. (L. Aegyptus) Egypt: cf. F. Egyptien. Cf. Gypsy.
Source: Websters Dictionary
(01 Mar 1998)
Egyptian haematuria Infection with Schistosoma haematobium, the eggs of which invade the urinary tract, causing cystitis and haematuria, and possibly an increased likelihood of bladder cancer.
Synonym: bladder schistosomiasis, Egyptian haematuria, endemic haematuria, urinary schistosomiasis.
(05 Mar 2000)
Egyptian ophthalmia <ophthalmology> A chronic infectious disease of the conjunctiva and cornea, producing photophobia, pain, lacrimation and blindness.
It is one of the oldest infectious diseases known to mankind, and dates back several thousand years with first documentation as early as the pharaonic era in Egypt.
The disease is associated with poor socioeconomic conditions in general: with overcrowding, poor personal and environmental hygiene and, in particular, with very limited access to water and sanitation. Trachoma has been eliminated as a blinding disease from several previously hyperendemic countries and regions, both through significant improvements in the socioeconomic status of populations and through specific control efforts.
Despite these successes, in many least developed countries of the world blinding trachoma continues to be an important public health problem. In some of the countries where trachoma was once hyperendemic, there remain residual pockets of blinding trachoma and complications, such as inturned eyelashes (trichiasis), which require eyelid surgery.
Today, the disease is found mainly in poor rural areas, including parts of central and south America, most African countries and some countries in the Eastern Mediterranean. Trachoma is still endemic in several Asian countries, but there is a lack of updated information from some major populations, e.g. In India and China.
The organism that causes this disease is Chlamydia trachomatis; a microorganism resembling both bacteria and viruses, which spreads through contact with eye discharge from the infected person (on towels, handkerchiefs, fingers, etc.) and through transmission by eye-seeking flies. Chlamydia trachomatis provokes an inflammatory reaction in the eye with formation of follicles in the conjunctiva. After years of repeated infections, the inside of the eyelids may be scarred so severely that the eyelid turns inwards with eyelashes rubbing on the eyeball. If untreated, this condition leads to blindness.
The World Health Organization is working towards global elimination of trachoma, which is responsible, at present, for at least 15% of the world's blindness. Worldwide, there are about 6 million people largely irreversibly blinded by trachoma, and an estimated 146 million cases of active disease in need of treatment, if blindness is to be prevented.
International efforts to eliminate trachoma as a blinding disease will be based on a combination of interventions known by the acronym "SAFE", which stands for Surgery for trichiasis (inturned eyelashes), Antibiotics, Facial cleanliness and Environmental improvement. These interventions will be community-targeted and will seek community involvement through the primary health care approach.
Origin: Gr. Trachoma = roughness
(07 May 1998)
Egyptian splenomegaly Term sometimes used as a synonym for schistosomiasis mansoni, although hepatomegaly and fibrosis are more consistently found than is an enlarged spleen.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hematuria
    Ç÷´¢(Áõ)
  • Egyptian
    ÀÌÁýÆ®ÀÇ;ÀÌÁýÆ®»ç¶÷
  • Egyptian cotton
    (½Ä)ÀÌÁýÆ®¸ñÈ­
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á